George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 10,750 shares at $650.00 ($7.0M) on 2021-11-16, disclosed to the SEC on 2021-11-18.
Seasonal sale ($7.0M) by Director — this insider has traded REGN in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $650.00 | 750 | $488K | 6.9% |
| 2 | $650.00 | 2,000 | $1.3M | 18.5% |
| 3 | $658.79 | 2,000 | $1.3M | 18.8% |
| 4 | $660.00 | 2,000 | $1.3M | 18.8% |
| 5 | $650.00 | 4,000 | $2.6M | 37.0% |
| Total | $653.50 avg | 10,750 |
| $7.0M |
| 100% |
| Filing → |
| REGN | SELL | 2024-02-26 | $3.4M | — | Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |